Advertisement

Bone fracture risk factors in prevalent hemodialysis patients

  • Patrícia João MatiasEmail author
  • Ivo Laranjinha
  • Ana Azevedo
  • Ana Raimundo
  • David Navarro
  • Cristina Jorge
  • Inês Aires
  • Marco Mendes
  • Carina Ferreira
  • Tiago Amaral
  • Célia Gil
  • Aníbal Ferreira
Original Article
  • 33 Downloads

Abstract

Bone fractures are an important cause of morbidity and mortality in hemodialysis (HD) patients. The aim of this study was to quantify the incidence of fractures in a cohort of prevalent HD patients and evaluate its relationship with possible risk factors. We performed a retrospective analysis of 341 patients, since they started HD (median of 51 months). Demographic, clinical, and biochemical parameters as well as vascular calcifications (VC) were evaluated. Fifty-seven episodes of fracture were identified with a median HD vintage of 47 months (incidence rate of 31 per 1000 person-years). Age (p < 0.001), female gender (p < 0.001), lower albumin (p = 0.02), and higher VC score (p < 0.001) were independently associated with increased risk of fracture, while active vitamin D therapy (p = 0.03) was associated with decreased risk. A significantly higher risk of incident fracture was also associated with higher values of bone-specific alkaline phosphatase (bALP) (p = 0.01) and intact parathyroid hormone (iPTH) levels either < 300 pg/mL (p = 0.02) or > 800 pg/mL (p < 0.001) compared with 300–800 pg/mL. In conclusion, bone fracture incidence in HD patients is high and its risk increases with age, female gender, lower serum albumin, and with the presence of more VC. Prevalent HD patients with low or high iPTH levels or increased bALP also had a higher fracture risk. Therapy with active vitamin D seems to have a protective role. Assessment of fracture risk and management in dialysis patients at greatest risk requires further study.

Keywords

Bone fracture Chronic kidney disease CKD-MBD Dialysis 

Notes

Acknowledgements

This study was presented, in part, at the 55th ERA-EDTA Congress, Copenhagen. The results presented in this paper have not been published previously in whole or part, except in abstract format. The authors thank Fernanda Gomes and Natália Gonçalves for the technical support.

Author contributions

PJM, IL, CG, and AF collaborated in study design. PJM, IL, and AR collected the data. PJM wrote the manuscript. IL, AA, AR, DN, CJ, IA, MM, CF, TA, CG, and AF participated in the final revision of the manuscript.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    Abbott KC, Oglesby RJ, Hypolite IO, Kirk AD, Ko CW, Welch PG, Agodoa LY, Duncan WE (2001) Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol 11:450–457CrossRefGoogle Scholar
  2. 2.
    Naylor KL, McArthur E, Leslie WD, Fraser LA, Jamal SA, Cadarette SM, Pouget JG, Lok CE, Hodsman AB, Adachi JD, Garg AX (2014) The three-year incidence of fracture in chronic kidney disease. Kidney Int 86:810–818CrossRefGoogle Scholar
  3. 3.
    Coco M, Rush H (2000) Increased incidence of hip fracture in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115–1121CrossRefGoogle Scholar
  4. 4.
    Jamal SA (2010) Bone mass measurements in men and women with chronic kidney disease. Curr Opin Nephrol Hypertens 19:343–348CrossRefGoogle Scholar
  5. 5.
    London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Neprol 15:1943–1951CrossRefGoogle Scholar
  6. 6.
    Adragão T, Herberth J, Monier-Faugere MC, Branscum AJ, Ferreira A, Frazao JM, Dias Curto J, Malluche HH (2009) Low bone-volume—a risk factor for coronary calcifications in hemodialysis patients. Clin J Am Soc Neprol 4:450–455CrossRefGoogle Scholar
  7. 7.
    K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease (2003). Am J Kidney Dis 42: S1–S201Google Scholar
  8. 8.
    Seeley AG, Browner WS, Nevitt MC, Genant HK, Scott JC, Cummings SR (1991) Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group. Ann Intern Med 115:837–842CrossRefGoogle Scholar
  9. 9.
    Bushinsky DA, Monk RD (1998) Electrolyte quintet: calcium. Lancet 352:306–311CrossRefGoogle Scholar
  10. 10.
    Adragão T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M, Negrao AP (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transpl 19:1480–1488CrossRefGoogle Scholar
  11. 11.
    Fink HA, Buzkova P, Garimella PS, Mukamal KJ, Cauley JÁ, Kizer JR, Barzilay JI, Jalal DI, Ix JH (2015) Association of Fetuin-A with incident fractures in community-dwelling older adults: the Cardiovascular Health Study. J Bone Miner Res 30:1394–1402CrossRefGoogle Scholar
  12. 12.
    Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL (2014) High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85:166–173CrossRefGoogle Scholar
  13. 13.
    Beaubrun AC, Kilpatrick RD, Freburger JC, Bradbury BD, Wang L, Brookhart MA (2013) Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients. J Am Soc Nephrol 24:1461–1469CrossRefGoogle Scholar
  14. 14.
    Fusaro M, Tripepi G, Noale M, Vajente N, Plebani M, Zaninotto M, Guglielmi G, Miotto D, Dalle Carbonare L, D’Angelo A, Ciurlino D, Puggia R, Miozzo D, Giannini S, Gallieni M (2013) High prevalence of vertebral fractures assessed by quantitative morphometry in hemodialysis patients, strongly associated with vascular calcifications. Calcif Tissue Int 93:39–47CrossRefGoogle Scholar
  15. 15.
    Hansen D, Olesen JB, Gislason GH, Abrahamsen B, Hommel K (2016) Risk of fracture in adults on renal replacement therapy: a Danish national cohort study. Nephrol Dial Transpl 31:1654–1662CrossRefGoogle Scholar
  16. 16.
    Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gresham JL, Mason N, Prutz KG, Young EW, Pisoni RL (2006) Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 70:1358–1366CrossRefGoogle Scholar
  17. 17.
    Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM (2006) PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47:149–156CrossRefGoogle Scholar
  18. 18.
    Blayney MJ, Pisoni RL, Bragg-Gresham JL, Bommer J, Piera L, Saito A, Akiba T, Keen ML, Young EW, Port FK (2008) High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int 74:655–663CrossRefGoogle Scholar
  19. 19.
    Kaji H, Suzuki M, Yano S, Sugimoto T, Chihara K, Hattori S, Sekita K (2002) Risk factors for hip fracture in hemodialysis patients. Am J Nephrol 22:325–331CrossRefGoogle Scholar
  20. 20.
    Magnusson P, Sharp CA, Magnusson M, Risteli J, Davie MW, Larsson L (2001) Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int 60:257–265CrossRefGoogle Scholar
  21. 21.
    Park JC, Kovesdy CP, Duong U, Streja E, Rambod M, Nissenson AR, Sprague SM, Kalantar-Zadeh K (2010) Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients. Hemodial Int 14:182–192CrossRefGoogle Scholar
  22. 22.
    Sardiwal S, Magnusson P, Goldsmith DJ, Lamb EJ (2013) Bone alkaline phosphatase in CKD-mineral bone disorder. Am J Kidney Dis 62:810–822CrossRefGoogle Scholar
  23. 23.
    Iimori S, Mori Y, Akita W, Kuyama T, Takada S, Asai T, Kuwahara M, Sasaki S, Tsukamoto Y (2012) Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients—a single-center cohort study. Nephrol Dial Transplant 27:345–351CrossRefGoogle Scholar
  24. 24.
    Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T (1999) Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287–293CrossRefGoogle Scholar
  25. 25.
    Barreto FC, Barreto DV, Moysés RM, Neves KR, Canziani ME, Draibe SA, Jorgetti V, Carvalho AB (2008) K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int 73:771–777CrossRefGoogle Scholar
  26. 26.
    Russo CR, Taccetti G, Caneva P, Mannarino A, Maranghi P, Ricca M (1998) Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis. Osteoporosis Int 8:443–448CrossRefGoogle Scholar
  27. 27.
    Pimentel A, Ureña-Torres P, Zillikens MC, Bover J, Cohen-Solal M (2017) Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation. Kidney Int 92:1343–1355CrossRefGoogle Scholar
  28. 28.
    Jokihaara J, Pörsti I, Pajamäki I, Vuohelainen T, Jolma P, Kööbi P, Kalliovalkama J, Niemelä O, Kannus P, Sievänen H, Järvinen TL (2006) Paricalcitol [19-nor-1,25-(OH)2D2] in the treatment of experimental renal bone disease. J Bone Miner Res 21:745–751CrossRefGoogle Scholar
  29. 29.
    Rix M, Eskildsen P, Olgaard K (2004) Effect of 18 months of treatment with alfacalcidol on in patients with mild to moderate chronic renal failure. Nephrol Dial Transpl 19:870–876CrossRefGoogle Scholar
  30. 30.
    Obi Y, Hamano T (2015) Isaka Y (2015) Prevalence and prognostic implications of vitamin d deficiency in chronic kidney disease. Dis Mark 2015:868961Google Scholar
  31. 31.
    Elder GJ (2007) Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5. Nephrology (Carlton) 12:90–94Google Scholar
  32. 32.
    Heaf JG, Joffe P, Marckmann P (2012) Vitamin D and stage 5 chronic kidney disease: a new paradigm? Semin Dial 25:50–58CrossRefGoogle Scholar
  33. 33.
    Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stähelin HB, Theiler R, Dawson-Hughes B (2012) A pooled analysis of vitamin d dose requirements for fracture prevention. N Engl J Med 367:40–49CrossRefGoogle Scholar
  34. 34.
    Ambrus C, Almasi C, Berta K, Deak G, Marton A, Molnar MZ, Nemeth Z, Horvath C, Lakatos P, Szathmari M, Mucsi I (2011) Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis. Int Urol Nephrol 43:475–482CrossRefGoogle Scholar
  35. 35.
    Carballido-Gamio J, Harnish R, Saeed I, Streeper T, Sigurdsson S, Amin S, Atkinson EJ, Therneau TM, Siggeirsdottir K, Cheng X, Melton LJ 3rd, Keyak J, Gudnason V, Khosla S, Harris TB, Lang TF (2013) Structural patterns of the proximal femur in relation to age and hip fracture risk in women. Bone 57:290–299CrossRefGoogle Scholar
  36. 36.
    Santos MFP, Hernández MJ, de Oliveira IB, Siqueira FR, Dominguez WV, Dos Reis LM, Carvalho AB, Moysés RMA, Jorgetti V (2018) Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with or without fractures. J Bone Miner Metab.  https://doi.org/10.1007/s00774-018-0902-7 Google Scholar
  37. 37.
    Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V (2004) Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89:4246–4253CrossRefGoogle Scholar
  38. 38.
    Asci G, Ozkahya M, Duman S (2007) The link between cardiovascular and bone disease in hemodialysis patients. Nephrol Dial Transpl Plus 22:iv217CrossRefGoogle Scholar
  39. 39.
    Toussaint ND, Elder GJ, Kerr PG (2009) Bisphosphonates in chronic kidney disease: balancing potential benefits and adverse effects on bone and soft tissue. Clin J Am Soc Nephrol 4:221–233CrossRefGoogle Scholar

Copyright information

© The Japanese Society Bone and Mineral Research and Springer Japan KK, part of Springer Nature 2019

Authors and Affiliations

  • Patrícia João Matias
    • 1
    • 2
    • 3
    • 4
    Email author
  • Ivo Laranjinha
    • 2
    • 3
    • 4
  • Ana Azevedo
    • 2
    • 3
  • Ana Raimundo
    • 1
    • 3
  • David Navarro
    • 1
    • 3
  • Cristina Jorge
    • 1
    • 2
    • 3
  • Inês Aires
    • 1
    • 2
    • 3
    • 4
  • Marco Mendes
    • 1
    • 3
  • Carina Ferreira
    • 2
    • 3
    • 4
  • Tiago Amaral
    • 2
    • 3
  • Célia Gil
    • 1
    • 2
    • 3
  • Aníbal Ferreira
    • 1
    • 2
    • 3
    • 4
  1. 1.Dialysis UnitNephrocare Vila Franca de XiraVila Franca de XiraPortugal
  2. 2.Dialysis UnitDialvercaForte da CasaPortugal
  3. 3.NIDANLisbonPortugal
  4. 4.Faculdade de Ciências MédicasNOVA Medical SchoolLisbonPortugal

Personalised recommendations